IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease
IL-17 e IL-17R: una diana terapéutica favorable para la enfermedad psoriásica
Leído
5455
Vecesse ha leído el artículo
3445
Total PDF
2010
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 63 | 112 | 175 |
| 2025 5 | 78 | 71 | 149 |
| 2025 4 | 74 | 57 | 131 |
| 2025 3 | 61 | 35 | 96 |
| 2025 2 | 52 | 42 | 94 |
| 2025 1 | 41 | 43 | 84 |
| 2024 12 | 40 | 35 | 75 |
| 2024 11 | 41 | 57 | 98 |
| 2024 10 | 34 | 65 | 99 |
| 2024 9 | 24 | 51 | 75 |
| 2024 8 | 42 | 85 | 127 |
| 2024 7 | 26 | 44 | 70 |
| 2024 6 | 38 | 32 | 70 |
| 2024 5 | 25 | 42 | 67 |
| 2024 4 | 31 | 37 | 68 |
| 2024 3 | 24 | 39 | 63 |
| 2024 2 | 34 | 59 | 93 |
| 2024 1 | 20 | 40 | 60 |
| 2023 12 | 20 | 26 | 46 |
| 2023 11 | 33 | 35 | 68 |
| 2023 10 | 21 | 26 | 47 |
| 2023 9 | 21 | 41 | 62 |
| 2023 8 | 20 | 26 | 46 |
| 2023 7 | 23 | 39 | 62 |
| 2023 6 | 25 | 34 | 59 |
| 2023 5 | 21 | 52 | 73 |
| 2023 4 | 14 | 22 | 36 |
| 2023 3 | 19 | 46 | 65 |
| 2023 2 | 17 | 31 | 48 |
| 2022 1 | 17 | 31 | 48 |
| 2022 12 | 25 | 30 | 55 |
| 2022 11 | 22 | 28 | 50 |
| 2022 10 | 15 | 25 | 40 |
| 2022 9 | 20 | 44 | 64 |
| 2022 8 | 16 | 48 | 64 |
| 2022 7 | 17 | 94 | 111 |
| 2022 6 | 36 | 49 | 85 |
| 2022 5 | 53 | 71 | 124 |
| 2022 4 | 30 | 54 | 84 |
| 2022 3 | 36 | 78 | 114 |
| 2022 2 | 19 | 46 | 65 |
| 2021 1 | 23 | 63 | 86 |
| 2021 12 | 18 | 42 | 60 |
| 2021 11 | 16 | 47 | 63 |
| 2021 10 | 32 | 61 | 93 |
| 2021 9 | 23 | 70 | 93 |
| 2021 8 | 25 | 56 | 81 |
| 2021 7 | 23 | 70 | 93 |
| 2021 6 | 16 | 52 | 68 |
| 2021 5 | 26 | 71 | 97 |
| 2021 4 | 16 | 81 | 97 |
| 2021 3 | 27 | 45 | 72 |
| 2021 2 | 14 | 57 | 71 |
| 2020 1 | 22 | 42 | 64 |
| 2020 12 | 15 | 38 | 53 |
| 2020 11 | 28 | 54 | 82 |
| 2020 10 | 5 | 22 | 27 |
| 2020 9 | 13 | 28 | 41 |
| 2020 8 | 12 | 28 | 40 |
| 2020 7 | 13 | 31 | 44 |
| 2020 6 | 23 | 27 | 50 |
| 2020 5 | 23 | 27 | 50 |
| 2020 4 | 15 | 20 | 35 |
| 2020 3 | 21 | 26 | 47 |
| 2019 5 | 1 | 0 | 1 |
| 2018 12 | 0 | 2 | 2 |
| 2018 9 | 1 | 2 | 3 |
| 2018 3 | 1 | 1 | 2 |
| 2018 2 | 10 | 17 | 27 |
| 2018 1 | 13 | 14 | 27 |
| 2017 12 | 12 | 21 | 33 |
| 2017 11 | 15 | 22 | 37 |
| 2017 10 | 5 | 17 | 22 |
| 2017 9 | 10 | 20 | 30 |
| 2017 8 | 10 | 10 | 20 |
| 2017 7 | 17 | 11 | 28 |
| 2017 6 | 24 | 22 | 46 |
| 2017 5 | 16 | 18 | 34 |
| 2017 4 | 18 | 27 | 45 |
| 2017 3 | 20 | 25 | 45 |
| 2017 2 | 8 | 21 | 29 |
| 2016 1 | 15 | 34 | 49 |
| 2016 12 | 20 | 17 | 37 |
| 2016 11 | 22 | 17 | 39 |
| 2016 10 | 30 | 16 | 46 |
| 2016 7 | 1 | 1 | 2 |
| 2016 6 | 0 | 8 | 8 |
| 2016 5 | 0 | 9 | 9 |
| 2016 4 | 0 | 5 | 5 |
| 2016 3 | 0 | 3 | 3 |
| 2016 2 | 0 | 12 | 12 |
| 2015 1 | 0 | 3 | 3 |
| 2015 12 | 0 | 17 | 17 |
| 2015 11 | 0 | 11 | 11 |
| 2015 10 | 0 | 13 | 13 |
| 2015 9 | 0 | 11 | 11 |
| 2015 8 | 0 | 10 | 10 |
| 2015 7 | 0 | 8 | 8 |
| 2015 6 | 0 | 8 | 8 |
| 2015 5 | 0 | 6 | 6 |
| 2015 4 | 0 | 1 | 1 |
| 2015 3 | 0 | 4 | 4 |
| 2015 2 | 2 | 1 | 3 |
| 2014 12 | 1 | 0 | 1 |
| 2014 11 | 1 | 0 | 1 |
Mostrar todo
